Cross-Neutralizing Antibodies against Cosmopolitan and Melanesian Strains of Human T Cell Leukemia/Lymphotropic Virus Type I in Sera from Inhabitants of Africa and the Solomon Islands
- 1 January 1994
- journal article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 10 (1) , 91-96
- https://doi.org/10.1089/aid.1994.10.91
Abstract
The so-called cosmopolitan strains of human T cell leukemia/lymphotropic virus type I (HTLV-I) from Japan, Africa, the West Indies, and the Americas differ only slightly (< 3%) in their genomic sequence. On the other hand, the Melanesian strains of HTLV-I are somewhat more divergent, exhibiting only 93% sequence similarity with the cosmopolitan strains. Despite this difference, sera from individuals infected with Melanesian strains cross-react with T cells infected with cosmopolitan strains of HTLV-I, indicating an overall conservation of the B cell immunoprevalent epitopes. Neutralizing antibodies against HTLV-I in sera from virus-infected Africans and Melanesians were assayed by determining their ability to block the formation of syncytia in cocultures of 8166 and T cell lines harboring either cosmopolitan or Melanesian HTLV-I isolates. All six African sera blocked the formation of syncytia with cells infected with HTLV-IC91-PL, a viral isolate from the United States. Similarly, all six Melanesian sera inhibited syncytium formation with cells infected with HTLV-IMEL3, a virus isolate from the Solomon Islands. Although most of these sera inhibited syncytium formation in cell cultures carrying the cosmopolitan as well as the Melanesian HTLV-I strains, neutralizing antibody titers tended to be higher against the homologous virus. All sera failed to inhibit syncytium formation when cells were infected with HTLV-II. These data indicate the involvement of one or more epitopes in syncytial formation, some of which are conserved in all strains of HTLV-I.(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 42 references indexed in Scilit:
- Neutralizing Antibody to Vesicular Stomatitis Virus (HTLV-I) Pseudotype in Infants Born to Seropositive MothersJapanese Journal of Cancer Research, 1993
- Characterization of a B-cell immunodominant epitope of human T-lymphotropic virus type 1 (HTLV-I) envelope gp46Cancer Letters, 1992
- Immunoglobulin Prophylaxis against Milkborne Transmission of Human T Cell Leukemia Virus Type I in RabbitsThe Journal of Infectious Diseases, 1991
- Inhibitory effect of maternal antibody on mother‐to‐child transmission of human T‐lymphotropic virus type IInternational Journal of Cancer, 1991
- Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological diseaseNature, 1990
- Genetic variation in AIDS virusesCell, 1986
- HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITYThe Lancet, 1986
- Human T‐cell leukemia virus type I: Pseudotype neutralization of Japanese And American isolates with human and rabbit seraInternational Journal of Cancer, 1985
- ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESISPublished by Elsevier ,1985
- Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphomaProceedings of the National Academy of Sciences, 1980